Brand-Name GLP-1 Medications for Weight Loss
Wegovy (semaglutide) and Zepbound (tirzepatide) are the two leading FDA-approved GLP-1 medications specifically for weight loss. Here is how they compare. If you are here looking into weight management clinic, the detail below covers scope, timing and what to check before you commit.
Key Differences
- Mechanism: Wegovy targets GLP-1 only. Zepbound targets both GLP-1 and GIP.
- Weight Loss: Zepbound shows ~22% average weight loss vs. ~15% for Wegovy in their respective trials.
- Insurance Coverage: Wegovy has been on the market longer and may have broader insurance coverage. Zepbound coverage is growing.
- Availability: Both have experienced shortages. Availability fluctuates — your provider can advise on current status in Gilbert.
- Cost: Similar list prices. Your out-of-pocket cost depends entirely on your insurance plan.
What Gilbert Providers Say
Local weight management providers generally offer both medications and help patients navigate insurance coverage, prior authorizations, and availability. The best medication is the one you can access consistently and tolerate well.
More Comparisons
Semaglutide vs. Tirzepatide: Which Is Right for You?GLP-1 Medications vs. Traditional Weight Loss ProgramsGLP-1 Medication vs. Weight-Loss Surgery
Not sure which comparison you need? Browse all comparisons or take the matching quiz.
Continue Your Research
Learn more before you decide — explore the guides, tools, and answers below.